PA
AMGN icon

Paralel Advisors’s Amgen AMGN Stock Holding History

Paralel Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38M Sell
6,565
-2,020
-24% -$691K 0.09% 72
2026
Q1 		$3.02M Hold
8,585
– – 0.13% 50
2025
Q4 		$2.81M Hold
8,585
– – 0.11% 55
2025
Q3 		$2.42M Buy
8,585
+10
+0.1% +$2.9K 0.09% 70
2025
Q2 		$2.39M Buy
+8,575
New +$2.43M 0.1% 79

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Paralel Advisors's AMGN Position: Q2 2026 in Review

Paralel Advisors reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $691K and leaving 6,565 shares worth $2.38M. The position accounts for 0.09% of the portfolio, ranked #72.

Paralel Advisors first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.02M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Paralel Advisors held 6,565 shares of Amgen worth $2.38M as of Q2 2026.
  • Paralel Advisors sold 2,020 Amgen shares in Q2 2026, an estimated $691K.
  • Amgen made up 0.09% of Paralel Advisors's portfolio in Q2 2026, its #72 holding.
  • Paralel Advisors first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Paralel Advisors's Amgen position peaked at $3.02M in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.